Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Tuesday 14 October 2014 4:56 am  |  Updated:  Friday 07 June 2019 1:44 pm

Ebola.com on sale for $150,000 by pair who invest in disaster domain names

By: Sarah Spickernell

Add as a preferred source on Google

Business partners Jon Schultz and Chris Hood are selling Ebola.com for $150,000, after purchasing it for an undisclosed sum in 2008.
 
The Ebola outbreak currently gripping West Africa has killed over 4,000 people since it began in Guinea in February, according to estimates by the World Health Organisation (WHO). 
 
While there is currently no certified cure for the disease, a number of pharmaceutical companies, such as GlaxoSmithKline and MAPP Pharmaceutical, are trying to develop one.
 
Schultz and Hood hope that one of these companies will see the benefits of owning the domain name. In an email to CNBC, Schultz said: 
 
"Ebola.com would be a great domain for a pharmaceutical company working on a vaccine or cure, a company selling pandemic or disaster-preparedness supplies, or a medical company wishing to provide information and advertise services.
 
"There could be many other applications as well. With so many people concerned about the disease, any advertisement referring people to Ebola.com should get an excellent response."  
 
The asking price is not set in stone, however: Schultz said the domain's price "is subject to change as the situation evolves."
 
Schultz is President of the firm Blue String Ventures, which specialises in “internet real estate investment, development and brand assistance”. They are making the sale through domain name broker DigitalDNA, which has already approached a number of pharmaceutical firms to gauge their interest. 
 
It is not the first time Schultz and Hood have put their entrepreneurial spirit into practice when it comes to possible disasters – they are also the owners BirdFlu.com, Fukushima.com, and PotassiumIodide.com, among others. Potassium iodide could be used to fight diseases resulting from the radiation released in a bioterrorism or nuclear attack. 
 
Their strategy, explained Schultz, is to buy "generic domains which we think we can develop or resell later at a profit.”
 
"Having seen the movie 'Outbreak,' I was entranced by the subject and couldn't resist buying the domain,” he explained. 

 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Brewdog chief executive quits after only one year

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Burnham tax plans spark investor rush to bank capital gains

  • As it happened: Stocks jump on defence and metals boost; Oil on track to shed a fifth on US-Iran peace hopes

More from City PM

  • LSE draws up ‘worst case scenario’ US listing flight risk

    Markets
    London Stock Exchange building exterior with financial district skyline, symbolizing global market activity and economic t...
  • Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

    Business Wire
  • ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

    Business Wire
  • Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology

    Business Wire
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Regulator wins decade-long pricing tussle with Pfizer

    Legal
    Hikma reported a jump in profit for 2024
  • Blackstone Raises its Largest Asia Private Equity Fund at $13.1 Billion

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy